Skip to content
Home/Companies/Biotech/FairJourney Biologics
FB

FairJourney Biologics

Biotech·Portugal·Exited 2024·Held 4yr

FairJourney Biologics is a biotech company, headquartered in Portugal.

Entry
2020
Hold
4yr
Exit
2024
Est. EV
–

Who owns FairJourney Biologics?

FairJourney Biologics was owned by GHO Capital through GHO Capital Fund II LP (2019 vintage) from 2020 to 2024, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

GHO Capital
Investor
GHO Capital
GHO Capital Fund II LP · 2019 · Buyout

Key facts

HQPortugal
SectorBiotech
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2024

More from GHO Capital Fund II LP

Other portfolio companies in the same fund.

Validant
Active
Business ServicesUnited States· 2022
Ardena
Active
PharmaBelgium· 2020
Sterling Pharma Solutions
Active
PharmaUK· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings